Stay updated on Long-term Esketamine Study in Depression: Clinical Trial
Sign up to get notified when there's something new on the Long-term Esketamine Study in Depression: Clinical Trial page.

Latest updates to the Long-term Esketamine Study in Depression: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe webpage has updated its version from v2.15.0 to v2.15.2 and has removed older dates from March 2025, replacing them with newer dates in April 2025.SummaryDifference0.2%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has been updated to include new information about treatment-resistant depression, specifically mentioning the oral antidepressants Sertraline and Venlafaxine XR, as well as a new identifier for a study. The previous detailed description of the study's methodology and phases has been removed.SummaryDifference11%
- Check30 days agoChange DetectedThe page has been updated to reflect the latest version as v2.14.4, replacing the previous version v2.14.3. The estimated last update posted has been removed.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has updated its version from v2.14.2 to v2.14.3 and has added new dates for March 2025 while removing previous dates from February 2025.SummaryDifference0.2%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.5%
- Check81 days agoChange DetectedThe webpage has updated its dates and locations, replacing older entries with new ones, including Sao Jose do Rio Preto, Brazil, and Gyeonggi-do, Korea, Republic of, along with new estimated update dates.SummaryDifference0.4%
Stay in the know with updates to Long-term Esketamine Study in Depression: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Esketamine Study in Depression: Clinical Trial page.